Scleroderma Trials in Pittsburgh, United States
Conditions / Scleroderma / Pittsburgh, United States
Clinical trials for Scleroderma investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03222492 | Brentuximab Vedotin for Systemic Sclerosis | COMPLETED | PHASE1/PHASE2 |
| NCT00377949 | Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients | COMPLETED | — |
| NCT06195072 | Platform Clinical Study for Conquering Scleroderma | RECRUITING | PHASE2 |
| NCT02915835 | Riociguat in Scleroderma Associated Digital Ulcers | COMPLETED | PHASE2 |
| NCT02370784 | Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma | COMPLETED | PHASE2 |
| NCT00764309 | Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis | COMPLETED | PHASE1/PHASE2 |
| NCT03274076 | Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc) | COMPLETED | PHASE1/PHASE2 |
| NCT05925803 | Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02396238 | Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR) | COMPLETED | NA |
| NCT00775463 | Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine | COMPLETED | PHASE2 |